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Abstract  
Oxysterols (oxidized derivatives of cholesterol an phytosterols) can be generated 
in the human organism through different oxidation processes, some requiring enzymes. 
Furthermore, oxysterols are also present in food due to lipid oxidation reactions caused 
by heating treatments, contact with oxygen, exposure to sunlight, etc., and they could 
be absorbed from the diet, at different rates depending on their side chain lenght.  
In the organism, oxysterols can follow different routes: secreted into the intestinal 
lumen, esterified and distributed by lipoproteins to different tissues or degraded, maily 
in the liver. Cholesterol oxidation products (COPs) have shown citotoxicity, apoptotic 
and pro-inflammatory effects and they have also been linked with chronic diseases 
including atherosclerotic and neurodegenerative processess. In the case of 
phytosterols oxidation products (POPs), the evidences for toxic effects need more 
research. Nevertheless, current knowledge suggest their relation to cytotoxic and pro-
apoptotic effects, although at higher concentrations than COPs. 
Recently, new beneficial biological activities of oxysterols are being under 
research. Whereas COPs are associated with cholesterol homeostasis mediated by 
different mechanisms, the implication of POPs is not clear yet. 
Available literature on sources of oxysterols in the organism, metabolism, toxicity 
and potential benefitial effects of these compounds are reviewed in this paper.  
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Introduction 
Oxysterols are oxidized derivatives of cholesterol and phytosterols, which are the 
main animal and plant sterols, respectively. Cholesterol is widely known for its 
association with atherosclerosis disease, while phytosterols have been proven to 
reduce serum cholesterol levels, decreasing the risk of cardiovascular diseases 
(Peterson, 1951; Vanhanen, et al. 1993; Miettinen, et al. 1995; Pelletier, et al. 1995). 
Nevertheless, cholesterol is a necessary constituent in the human organism, fulfilling 
important functions: maintenance of cell membranes, generation of steroid hormones, 
bile acids production…(Simons and Ikonen, 2000). Hence, cholesterol can be 
endogenously produced. On the other hand, phytosterols must be acquired from the 
diet; oils, spreads, nuts and seeds are all rich in phytosterols. Among these 
compounds, the most abundant are sitosterol and campesterol; stigmasterol and 
brassicasterol however, are less common. Amounts between 2-3g/day have been 
demonstrated to reduce serum LDL-cholesterol levels in humans  by 10% (Katan et al., 
2003; Berger et al., 2004). These doses are higher than the usual dietary intake, and 
nowadays, phytosterol-enriched foods are commercially available.  
The structures of cholesterol and phytosterols are very similar (Fig. 1); they both 
have a steroid nucleus and a hydroxyl group in C-3. Due to the presence of a double 
bond between C5-C6, sterols can undergo oxidative processes (Hovenkamp et al., 
2008). In contrast, plant stanols do not have this double bond and are unlikely to 
oxidize (Soupas et al., 2004). The difference between cholesterol and phytosterols 
resides in the side chain, located in C-17. Compared to cholesterol, phytosterols have 
different substitutions in C-24 (Hovenkamp et al., 2008).  
<Insert Figure 1> 
The oxidation of the C5-C6 double bond, or of those in other positions in the 
steroid ring or side chain of sterols, results in the formation of oxysterols or sterol 
oxidation products (SOPs). In the case of cholesterol oxidation, the resulting products 
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are usually named COPs (cholesterol oxidation products) and when phytosterols are 
oxidized, the resulting products are named POPs (phytosterol oxidation products).  
COPs have been studied and identified since 1966 when they were first detected 
in human atheromatous plaques (Brooks et al., 1966). In the 90s, the isotope dilution 
mass spectrometry enabled the study of COPs in human plasma (Breuer and 
Björkhem, 1990; Dzeletovic et al., 1995). Since then, 7α-hydroxycholesterol (7α-HC), 
7β-hydroxycholesterol (7β-HC), 7-ketocholesterol (7-KC), 5α,6α-epoxycholesterol 
(5α,6α-EC), 5β,6β-epoxycholesterol (5β,6β-EC), 3β,5α,6β-cholestanetriol, 24-
hydroxycholesterol (24-HC), 25-hydroxycholesterol (25-HC) and 27-hydroxycholesterol 
(27-HC) have been found in human biological samples. 
On the other hand, POPs were not discovered until 1983, when α and β-
epoxydes of sitosterol were quantified in the plasma of a patient with Waldenström´s 
macroglobulinaemia (Brooks et al., 1983). Later, other oxysterols, mainly 
epoxysitosterols, were identified in phytosterolemic patients, but not in healthy 
volunteers (Plat et al., 2001). Nevertheless, recently, several POPs have been found in 
plasma of healthy subjects (Grandgirard et al., 2004a). β-epoxysitostanol and 
sitostanetriol were the most abundant, while campestanetriol, α-epoxysitostanol, 7-
ketositosterol and 7β-hydroxysitosterol concentrations were lower. Menéndez-Carreño 
et al. (2008a) found 7α-hydroxysitosterol (47.3 ng/mL) and 7β-hydroxysitosterol (49.0 
ng/mL) in the serum of healthy volunteers. 
COPs are now thought to be potentially involved in the initiation and progression 
of major chronic diseases including atherosclerosis, neurodegenerative processes, 
diabetes, kidney failure, and ethanol intoxication (Guardiola et al., 1996, 2002; Sottero 
et al., 2009), while POPs have been proven to be associated with atherosclerosis and 
cytotoxic effects, although at high doses (Meyer et al., 1998; Maguire et al., 2003). For 
these reasons, this present review intents to clarify the different oxysterol sources, their 
biological effects and their potential toxicity.  
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Sources of oxysterols 
There are three trains of thought that could explain the presence of oxysterols in 
human plasma; 1) In vivo transformation of cholesterol and phytosterols in cells, blood 
and tissues to form oxysterols. This endogenous source does not appear to explain the 
presence of all the COPs and POPs in human plasma and tissues. 2) In vivo oxidation 
of cosmetic product phytosterols in the skin (Tonello, 2006). 3) An exogenous source: 
Absorption of oxysterols from the diet, although the contribution of dietary COPs and 
POPs to the human plasma and tissues is still unclear.  
Endogenous sources of oxysterols 
Cholesterol and phytosterols in the diet 
Cholesterol is found in animal food products such as eggs, milk, cheese, dairy 
products, red meat (beef, pork), ham, liver, fish and seafood. The American Heart 
Association recommends an intake of less than 300 mg/day of cholesterol for healthy 
people. A European Prospective Investigation into Cancer (EPIC) study in Norfolk 
revealed that cholesterol mean intake was 260 mg/day (Andersson et al., 2004). 
However, the intake range was 150-450 mg/day (Escurriol et al., 2010). 
Phytosterols are synthesized by plants; hence we obtain them from the diet. The 
main sources of phytosterols are oils, spreads, nuts and seeds, and in lesser quantity 
in cereals and bakery products, vegetables and fruits (Conchillo et al., 2005a). In 2004, 
in the EPIC study developed in Norfolk, the estimated dietary intake of phytosterols 
ranged from 178 mg/day to 463 mg/day (Andersson et al., 2004). Later, in a study 
carried out in Germany the estimated dietary intake was 150-400 mg/day (Kuhlmann et 
al., 2005). Recently, another EPIC study carried out in Spain reveals that phytosterol 
mean intake is around 315 mg/day (Escurriol et al., 2010). In general, the consumption 
of plant sterols in Asian cultures (including algae in their diets) and vegetarians is much 
higher. However, to get a significant reduction (10-15%) of serum cholesterol a 
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consumption of 2-3 g/day of phystosterols is required (Katan et al., 2003). This is one 
of the reasons why many phytosterol-enriched foods have been commercialised since 
1995, when the first enriched fat yellow spread was launched. With the inclusion of 
these enriched foods in the diets, the dietary intake of phytosterols increases (Conchillo 
et al., 2005a; Kuhlmann et al., 2005).  
Cholesterol and phytosterol absorption  
Cholesterol is preferentially absorbed (56-60%) by the human intestine in 
comparison to phytosterols, probably because of the different side chain structure 
(Bosner et al., 1999). Different absorption rates have been described for plant sterols, 
mainly depending on the sterol nucleus and the length of the side chain. Absorption is 
about 10% for campesterol and about 4-7% for sitosterol (Salen et al., 1992; 
Heinemann et al., 1993; Lütjohan et al., 1995) whereas lower rates were shown by 
Ostlund et al. (2002), who reported absorptions of 0.5% and 1.89% for sitosterol and 
campesterol, respectively, using dual stable isotopic tracers.  
Sterol transformation in vivo 
Dietary and endogenous cholesterol and dietary phytosterols are transformed 
into different metabolites in human cells. Oxidation of sterols occur following different 
pathways: non-enzymatic (provoked by radical mechanism) and enzymatic oxidations. 
The non-enzymatic ones mainly affect the sterol ring while the enzymatic ones react in 
the side chain of sterol structures (Ryan et al., 2009). However, there are some 
exceptions: 25-HC and 7α-HC can be generated by both metabolic pathways. 
a) Non-enzymatic oxidation 
Cholesterol is attacked by reactive oxygen species (ROS) abstracting an allylic 
hydrogen atom at C-7 of the sterol ring. The radical generated can react with oxygen to 
form a cholesterol peroxyl radical, which further reacts abstracting a hydrogen and 
generates the relatively stable cholesterol 7α/β- hydroperoxides (Brown and Jessup, 
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2009). At this point, hydroperoxides may continue oxidizing non-enzymically or 
enzymes will reduce them to epoxycholesterols. The non-enzymatic oxidation 
generates 7α/β- HC and 7-KC, which are the major non-enzymatic oxysterols present 
in most tissues (Fig. 2) (Brown and Jessup, 2009).  7α/β-hydroxy and 7-keto 
derivatives of phytosterols are also formed by auto-oxidation in in vitro studies (Lampi 
et al., 2002; Grandgirard et al., 2004c). 
< Insert Figure 2> 
Regarding in vivo experiments, it is suggested that POPs may be also formed by 
non-enzymatic oxidation reactions, although no evidence is still available concerning 
human studies (Hovenkamp et al., 2008). Aringuer and Enroth (1974) reported the 
autooxidation of sitosterol in rat liver fractions, forming β-epoxysitosterol in 3 to 4 fold 
excess over α-epoxysitosterol. Both epoxydes were susceptible for conversion into 
sitostanetriol. On the other hand, Grandgirard et al. (2004b) also in a study carried out 
with rats, showed that sitostanetriol and campestanetriol were not formed in vivo from 
phytosterols.  
b) Enzymatic oxidation 
24-, 25- and 27- HCs are generated by enzymatic side-chain hydroxylation of 
cholesterol (Rozner and Garti, 2006). Sterol 27-hydroxylase (CYP27A1) and 
cholesterol 24-hydroxylase (CYP46A1) are P450 enzymes expressed in liver and 
macrophages, and neural cells of the brain and retina, respectively (Björkhem et al., 
1998; Brown and Jessup, 2009). They catalyse the hydroxylation reactions to form 27- 
and 24- HCs. Cholesterol 25-hydroxylase (Ch25h) is the enzyme responsible for 
generating 25-HC (Fig. 2) and it is expressed at very low levels. Nevertheless, it is very 
interesting, since its product (25-HC) regulates the sterol regulatory element binding 
protein (SREBP) for cholesterol synthesis (Russell, 2000). Non-enzymatic oxidation of 
25-HC has also been described (Smith, 1981), although the main source of this 
oxysterol is the enzymatic oxidation. Similarly, 7α-HC can be enzymatically generated 
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(Rozner and Garti, 2006) by 7α-hydroxylase and 7-ketone dehydrogenase (Smith, 
1996). 
In addition, there are some enzymes (5α,6α-epoxydase) that reduce 
hydroperoxides to 5,6-ECs. These ECs can be further converted to their triol end 
products via hydration in an acidic environment (Tai et al., 1999). 
With regard to POPs, hydroxylases (Aringer et al., 1976) and other enzymes 
could be involved in their oxidation. Nonetheless, the studies in this field are limited 
(Hovenkamp et al., 2008). 
The main oxysterol structures are shown in Figure 3.  
<Insert Figure 3> 
Phytosterol oxidation in the skin 
It was pointed out that POPs can be synthesized in the human skin by UV 
radiation (Tonello, 2006). Currently, several cosmetic products are enriched with or 
composed of phytosterols, which are absorbed by the skin. With this, UV light could 
catalyse the oxidation reactions of the plant sterols. However, there is a lack of 
evidence in this field and further studies are required.  
Exogenous sources of oxysterols  
COPs and POPs in the diet 
All foods containing cholesterol and phytosterols are susceptible to oxidation 
before entering the organism; especially those which have been exposed to heating 
treatments in the presence of oxygen or have been stored for long periods subjected to 
sunlight and oxygen. Hence, the source of oxysterols may be exogenous too 
(Guardiola et al., 2002; Leonarduzzi et al., 2002). 
Lipid oxidation reactions not only usually cause food spoilage from the sensory 
point of view, but also induce chemical changes that might compromise their safety for 
consumption. Several studies have demonstrated that the same oxidation reactions as 
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in endogenous pathways occur in foods, mainly during heating treatments and long-
term storage. COPs and POPs have been detected in different groups of foods, such 
as oils, dairy products, eggs and egg products, meat and meat products, seafood and 
seafood products and several enriched food products (Table 1). Specifically, the 
amount of COPs in meat products ranges from 0.1 μg/g (beef) to 18.7 μg/g 
(mortadella), while in seafood products up to 19.4 μg/g (Brazilian Sardines) and 33.6 
μg/g (anchovies). For butter and spread, the content of oxysterols is around 13-27 µg 
COPs per gram and 13 µg POPs per gram, respectively. For instance, in a portion of 
25 g of these products, <0.68 mg of COPs would be consumed in the case of butter, in 
contrast to 0.33 mg of POPs per 25 g of spread. The amount of POP consumed in 25 g 
of phytosterol-enriched spread would be much higher (1.16 mg). 
 It has been demonstrated that while cholesterol and phytosterol oxidation 
products are similar, when heat-treated under similar conditions, COP concentrations 
produced are higher (Xu et al., 2009). 7α/β-hydroxysterols, 7-ketosterols, α/β-
epoxysterols, and triols are the most detected oxidation products (Grandgirard et al., 
2004c; Soupas et al., 2004; Johnsson and Dutta, 2006; Menéndez-Carreño et al., 
2008b). Nonetheless, some authors have also quantified 24- hydroxystigmasterol, 25-
HC, 19-HC and 20α-HC (Echarte et al., 2001; Conchillo et al., 2005b; Johnsson and 
Dutta, 2006). 
<Insert Table 1> 
The amount of oxysterols may be very heterogeneous in the same type of food. 
There are several factors that influence the formation of cholesterol and phytosterol 
oxidation products. Hence, it is of great interest to study the implication of these factors 
and to avoid them in order to decrease oxysterol concentrations in foods. 
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Factors influencing oxysterol concentrations in the diet 
a) Heat treatment 
Heat treatments have marked effects on the rate of lipid auto-oxidation. 
Increasing temperature produces greater concentrations of free radicals due to the 
acceleration of the propagation reactions and lipid hydroperoxide decomposition. 
These free radicals promote the initiation and propagation of lipid auto-oxidation 
(Soupas et al., 2004). The oxidation reaction is directly related to the temperature of 
the heat treatment. Commercial stigmasterol treated at 100ºC for seven days was less 
oxidized than the same sample treated at 180ºC for 1 hour (Kemmo et al., 2005). 
Similarly, after treating commercial cholesterol and β-sitosterol at 150ºC for 60 minutes, 
COPs and POPs were detected, but not at 120ºC (Xu et al., 2009) or 100ºC (Yen et al., 
2010). 
Studies developed with food samples, also show a direct relation between heat 
intensity and oxysterol formation. Higher contents of COPs were quantified in roasted 
salmon treated at 200ºC for 30 minutes compared with the fried samples (180ºC-four 
minutes). The oxidation was proportional to the acidity index (Echarte et al., 2001). In 
addition, chicken and beef samples treated in the microwave (900W-three minutes; 
internal temperature of the samples at the end of the process: 100ºC) formed more 
cholesterol oxidation products than the ones fried with olive oil (180ºC-six minutes; 
internal temperature: 85-90ºC) (Echarte et al., 2003).  
Nevertheless, under drastic heating conditions such as 180ºC for two hours in 
presence of oxygen, the level of oxidation is so high that it degrades the formed COPs 
and POPs that formed from cholesterol and β-sitosterol pure standards, respectively 
(Xu et al., 2009) and stigmasterol standards (Menéndez-Carreño et al., 2010). A 
specific example of this was found in phytosterol-enriched milk which showed higher 
oxysterol levels post-treatment under microwave conditions for 1.5 minutes than for two 
 10
minutes (Menéndez-Carreño et al., 2008b), suggesting that oxysterols suffer further 
oxidation and degradation processes. 
Recently, higher concentrations of POPs were found in crude hazelnut oil than in 
the refined (Azadmard-Damirchi and Dutta, 2009). These results suggest that heat 
treatment in refining processes induces not only the formation of POPs, but also their 
degradation. 
b) Storage 
The effect of packaging on the oxidation reactions of sterols have been widely 
studied, since light, room temperature and presence of oxygen are critical factors in 
degradation processes.   
Regarding COPs, a 2-month vacuum packaging of Milano-type sausages was 
found to be less efficient in controlling the COP formation than a 2-month protective 
atmosphere storage, detecting amounts of 1.90 μg/g and 1.37 μg/g of COPs, 
respectively (Zanardi et al., 2002). Similar results were obtained in other studies 
(Conchillo et al., 2005b; Valencia et al., 2008), showing that the lack of oxygen in the 
modified atmosphere packaging is greater than in the vacuum one, and therefore the 
protection of food samples from oxidation is superior. Also, cooked samples stored 
under frozen conditions were found to suffer more oxidation processes than raw ones 
(Conchillo et al., 2005a), demonstrating that cooking promotes cholesterol oxidation 
during storage.  
With regard to POPs, they could be generated by photooxidation of the sterol ring 
mainly by sunlight, although artificial UV and irradiation also induce oxidation (Zhang et 
al., 2006). These results show that photooxidation depends on the dose rate (length of 
exposure); shorter but more intense treatments have lower oxidation effects. However, 
intense treatments could further oxidize POPs, similar to the effect of drastic 
temperatures in heat treatments. Hence, the effect of light in the formation of POPs 
should be extensively studied.  
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c) Matrix 
Besides food processing (heat treatment) and storage, the matrix in which sterols 
are contained has a great influence on oxidation reactions. There is a correlation 
between the degree of saturation of the lipid matrix and the sterol oxidation rate. Pure 
sterols are oxidized to a greater extent than sterols when contained in unsaturated and 
saturated matrix (Xu et al., 2009). Comparing the unsaturated and saturated matrix, in 
the former, the sterol oxidation rate was lower at high temperatures (>140ºC), probably 
owing to the facility of unsaturated fatty acid to oxidation, which protects sterols from 
oxidation. However, at low temperatures (<140ºC), the oxysterol formation was higher 
in the unsaturated matrix. The mechanism for this effect is not clear, but it seems to be 
that sterols react more rapidly in a matrix in which oxidation occurs more easily 
(Soupas et al., 2004).  
The omega-6/omega-3 fatty acids rate (W6/W3) is also related to cholesterol 
oxidation. Chicken and roasted salmon samples have higher W6/W3 ratios than beef, 
raw and fried salmon samples, respectively. In addition, chicken and roasted salmon 
samples have been shown to generate greater amounts of COPs than other samples 
(Echarte et al., 2001; 2003). Yen et al. (2010) observed that 500 μg/mL of conjugated 
linoleic acid (CLA) when added to cholesterol standards, prevented cholesterol from 
oxidation at 150ºC. 
In addition, the different effects of oil and oil-water emulsion matrix have been 
studied in the formation of oxyphytosterols. The phytosterol oxidation rate in bulk oil 
have been found to be lower than the one in the oil-water emulsion (Cercaci et al., 
2006), suggesting that oil-water surface allows more interactions with aqueous phase 
prooxidants. 
Finally, a number of studies have revealed that the addition of antioxidant to the 
food matrix can prevent cholesterol and phytosterol oxidation at high temperatures. Xu 
et al. (2009) observed that 200 ppm of natural and synthetic antioxidants protect 
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cholesterol and β-sitosterol standards against oxidation at 180ºC; in addition, natural 
antioxidants (α-tocopherol, quercetin and green tea catechins) were stronger than the 
synthetic butylated hydroxyl toluene (BHT) inhibiting COP and POP generation. D´Evoli 
et al. (2006) showed that rosemary (Rosmarinus officinalis, L.) prevents the formation 
of sitosterol oxides in extra virgin olive oil at 180ºC. In a comparative study, fewer 
oxysterols were formed in green tea extract-enriched rapeseed oil than in rosemary 
and BHT-enriched ones. However, the POP content in rapeseed oil without 
antioxidants was higher than in the oil enriched with each of the three antioxidants 
(Kmiecik et al., 2009). 
d) Esterification of phytosterols 
In commercial phytosterol-enriched foods, phytosterols are added as esters 
formed with fatty acids as their solubility enables an easier incorporation compared to 
non-esterified sterols (Brufau et al., 2008). Recent studies that compared the oxidation 
profiles of a phytosterol-enriched commercial spread and a non-enriched spread have 
shown that phytosterol oxidation rate was lower in the one that was enriched. These 
results suggest that natural phytosterol are oxidized more easily than the ones that 
were added (Conchillo et al., 2005a). With heat treatments, however, the oxidation 
seems to be greater in phytosteryl esters; during prolonged heating at 100ºC, 
phytosteryl esters were more reactive than free phytosterols, while at 180ºC, the 
formation of oxidation products was similar in both cases (Soupas et al., 2005). 
COP and POP absorption 
Several studies in rats, mice, hamsters and rabbits have shown that different 
COP compounds can be absorbed in the intestines. The absorption of COPs is lower 
than that of cholesterol, probably due to the lower solubility of COPs in micelles, the 
lower susceptibility to esterification in enterocytes and the cytotoxic effects in mucosal 
cells which could explain the reduced lymph flow in rats that had been given COPs 
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(Osada et al., 1994).  Also, each type of COP is absorbed to different degrees; 7β-HC, 
7-KC and 5α,6α-EC are detected in greater amounts than 5β,6β-EC and 25-HC, which 
are not quantified in some studies done on rabbits and healthy humans (Osada et al., 
1994; Linseisen and Wolfram, 1998; Vine et al., 1998). 
A correlation exists between serum levels of COPs and their concentration in the 
diet. In rabbits that had been fed with COP-enriched diet, increased concentrations of 
COPs in plasma were found compared to those in the control diet group (Vine et al., 
1998; Ubhayasekera et al., 2010a). Also, a diet containing highly oxidized lipids has 
been found to significantly increase the contents of oxycholesterols in meat, liver and 
plasma of chickens (Ubhayasekera et al., 2010b). These authors concluded that meat 
products from animals fed a diet containing higher levels of oxidized lipids may result in 
higher ingestion of oxycholesterols by humans.  
Similarly, studies carried out in healthy humans have proven that after a diet 
containing 400 mg of α-EC, serum α-EC can be detected, in comparison with the 
control group in which α-EC was not quantified (Staprans et al., 2003). Linseisen and 
Wolfram (1998) have found that the intake of parmesan cheese and salami (providing 
0.84 mg of unesterified COP and 2.64 mg of COP acyl esters) raises plasma COP 
levels. Free oxidized cholesterol concentration increased three hours after the meal, 
but with very high interindividual variation. In contrast, total COP levels in plasma were 
up to 100-fold higher 6-8 hours after the intake of salami and parmesan, while the 
variation was lower (Linseisen and Wolfram, 1998).  
Regarding POP absorption, results from animal studies have suggested that 
similar to phytosterols, there is a rise in plasma POP concentrations after a dietary 
intake of POPs. In hamsters that had been fed with 2500 ppm of POPs in the diet, 
803.3 ng/mL of POPs were found compared with only 32.6 ng/mL of POPs in the 
control group. In the aorta, kidney and heart lipids, the phytosterol oxidation products 
were up to 26-fold higher with a 2500 ppm POP diet than with the control diet. In liver 
lipids, the increase was up to 350-fold (Grandgirard et al., 2004d). 
 14
There is a relation between the phytosterol from which the oxidized form 
originates and the absorption of the oxidized derivatives. In a study carried out by 
Grandgirard et al. (2004d), oxycampesterols represented 20-30% of the identified 
POPs in the tissues: this is greater in proportion than in the diet (12.7%) and is 
probably due to a better absorption. In other studies, lymphatic recovery of campesterol 
oxidation products was greater than those of oxysitosterols (Grandgirard et al., 1999; 
Tomoyori et al., 2004).  Therefore, it seems that the length of the side chain of 
phytosterol oxidation products is linked to their absorption; the longer the side chain, 
the lower the absorption level. Thus, oxidized derivatives of stigmasterol were not 
identified in plasma and tissues (Grandgirard et al., 2004d). 
In addition, the type of oxidation could be related to a different rate of absorption. 
7β-hydroxycampesterol and 7β-hydroxysitosterol are the most abundant types of POPs 
in mice’ and hamsters’ plasma and tissues (Grandgirard et al., 2004d; Tomoyori et al., 
2004), suggesting that these compounds are better absorbed. α-epoxyphytosterols and 
7-ketophytosterols are presented at lower levels, probably due to rapid metabolization 
to triols and other compounds (Grandgirard et al., 1999; 2004d). Hence, the main 
POPs in tissues are triols and 7β-hydroxyphytosterols (Grandgirard et al., 2004d). 
However, when comparing the absorption of phytosterols with that of oxyphytosterols, 
the results obtained were controversial; in some cases phytosterol absorption was 
greater (Grandgirard et al., 1999), and vice versa in others (Tomoyori et al., 2004). 
Nevertheless, few studies have still measured the in vivo absorption of oxydized 
phytosterols (Ryan et al., 2009). 
In summary, oxysterols can be incorporated in plasma and tissues through a diet 
containing oxidized sterols. Nevertheless, a part of absorbed oxysterols come from the 
liver, where phytosterols and cholesterol are oxidized enzymatically and non-
enzimatically. Hence, in several studies, the sterol oxidation concentrations found in 
plasma and tissues are higher than those performed in the test diets (Linseisen and 
Wolfram, 1998; Grandgirard et al., 2004d). 
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Oxysterols in the organism 
Distribution and metabolism 
Oxysterols incorporated through the diet or excreted by the liver can be absorbed 
in human intestines. Once the oxysterols enter the enterocyte, they can follow different 
routes as is explained below (Fig. 4).  
<Insert Figure 4> 
a) Return to the intestine by ABCG5 and ABCG8 
Part of the absorbed phytosterols and cholesterol are secreted back into the 
intestinal lumen by transporters ABCG5 and ABCG8 which are a subfamily of ATP-
binding cassette transporters. Oxysterols might be pumped back into the gut through 
this route (Hovenkamp et al., 2008). However, there have not been any specific studies 
about the implication of ABCG5 and ABCG8 in oxysterol transport.  
b) Esterification and distribution 
Most oxysterols measured in plasma and tissues are predominantly esterified 
(Linseisen and Wolfram, 1998; Staprans et al., 2003), suggesting that they are good 
substrates for acyl-coA cholesterol acyl transferase (ACAT) in cells and lecitin 
cholesterol acyl transferasa (LCAT) in the circulation (Gill et al., 2008).  
Once the ACAT in the enterocyte reacts with oxysterols, they are incorporated to 
chylomicrons and later to Very Low Density Lipoproteins (VLDL), Low Density 
Lipoproteins (LDL) and High Density Lipoproteins (HDL) (Staprans et al., 2003; 2005). 
Hence, oxysterols can be transported to different cells of the organism.  
COPs amounts in chylomicrons, LDL and HDL increased 2h after a COP-
enriched meal (400 mg of α-EC), while little α-EC was detected in VLDL. COPs 
remained in chylomicrons until 8h, but at 72h the circulating α-EC was found mainly in 
LDL, and less in HDL (Staprans et al., 2003). This proves that the oxidized sterol 
products increased much more in LDLs than in other lipoproteins after the intake of a 
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COP test diet. These results suggest that COPs may play an important role in 
atherogenesis, as it will be explained later in this text. 
7α/β-HCs and 7-KC are the most quantified oxysterols in lipoproteins and their 
concentrations are greater than those found in the test diets, suggesting that they are 
also synthesized endogenously (Linseisen and Wolfram, 1998; Vine et al., 1998).  
As far as POPs are concerned, their presence in heart, kidney, aorta and other 
tissues demonstrates that these types of sterols are also transported in lipoproteins 
(Grandgirard et al., 2004d). 
c) Further reactions or metabolism 
Oxysterols can be metabolized or degraded to other compounds, mainly in the 
liver. Oxycholesterols are found to be further oxidized or reduced by enzymes.  Some  
of them are key enzymes of the bile acid biosynthesis, such as 7α-hydoxylase and 27-
hydorxylase (Ryan et al., 2009).  CYP27A1 can metabolize 7-KC to 27-hydroxylated-7-
ketocholesterol and further to water-soluble metabolites which can be eliminated from 
cells (Lyous and Brown, 2001; Larsson et al., 2007).  On the other hand, 7-KC can also 
follow a reduction route, being converted to 7β-HC by 11β-hydroxysteroid 
dehydrogenase type1 (Schweizer et al., 2004; Larsson et al., 2007).  
Cholesterol sulfotransferase enzyme (SULT2B1b) usually sulfates the 3β-hydroxil 
group of cholesterol, but oxysterols also have been found to be substrates of this 
enzyme (Fuda et al., 2007). SULT2B1b is expressed in retina, skin, platelets, liver and 
other tissues; hence, this route could be an important oxysterol excretion pathway 
(Higashi et al., 2004; Yanai et al., 2004; Fuda et al. 2007). 
Excretion 
Most of the oxysterols can be only eliminated from cells through specific 
membrane lipid transporters as a consequence of their hydrophobicity. Apart from the 
ABCG5 and ABCG8 transporters that pump back oxysterols to the intestine, there are 
other ATP-binding cassette transporters involved in oxysterol excretion. ABCA1 and 
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ABCG1 are mainly located in the macrophages and liver to transport oxidized sterols 
and other molecules out of the cell (Brown and Jessup, 2009).  
Toxicity and pathological effects of oxysterols 
COPs are associated with the initiation and progression of major chronic 
diseases including atherosclerosis, neurodegenerative processes, diabetes, kidney 
failure, and ethanol intoxication (Sottero et al., 2009). They provoke an imbalance of 
the ratio between oxidative and reductive biochemical reactions (oxidative stress) 
which acts on all organism levels from cell signalling to disease expression through up-
regulation of inflammation, apoptosis and fibrosis. 
COPs compared to unoxidized cholesterol have demonstrated stronger 
pathological and toxic effects by at least one to two orders of magnitude (Poli et al., 
2004; Van Reyk et al., 2006). This difference could be explained by the presence of a 
further oxygen group, which renders COPs more polarity and water-solubility, hence 
enabling COPs to pass through lipophilic membranes and redistribute into cells more 
efficiently than cholesterol (Sottero et al., 2009). The implications of POPs in 
atherosclerosis, neurodegenerative processes and other chronic diseases are still 
unknown. However, they have been associated with cytotoxic and pro-apoptotic effects 
(Meyer et al., 1998; Adcox et al., 2001; McCarthy et al., 2005).  
Cytotoxicity and apoptotic effects of oxysterols 
The cytotoxic effects of COPs have been studied in the last 25 years in the 
macrophages, fibroblasts, vascular cells, cancer cells and smooth muscle cells (Peng 
et al., 1985; Raaphorst et al., 1987). It has been demonstrated that the mode of cell 
death is by apoptosis (O´Callaghan et al., 2001). To analyse the cytotoxic and 
apoptotic effects of COPs, several mechanisms such as cell viability, DNA 
fragmentation, lactate deshydrogenase leakage, mitochondria dehydrogenase activity, 
glutathione concentration and caspase activity have been used, (Adcox et al., 2001; 
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O´Callaghan et al., 2001; Meynier et al., 2005; Prunet et al., 2005; Vejux and Lizard, 
2009).  
COPs in vitro were five times more cytotoxic than POPs (Meyer et al., 1998). This 
was also shown in other studies in which higher concentrations of POPs (120 μM) were 
required for the same cytotoxic effects of 60 μM of COPs (Adcox et al., 2001; Maguire 
et al., 2003; Roussi et al., 2005; 2006; 2007). However, POPs and COPs have different 
cytotoxic routes (Ryan et al., 2005). This difference was demonstrated when α-
tocopherol, γ-tocopherol, and β-carotene antioxidants were protected against the 
cytotoxic effects of 7β-HC, but not against the toxicity of POPs.  
Several cytotoxic routes have been proposed for COPs: perturbation of the 
intracellular calcium levels, intracellular ROS overproduction, mitochondrial and 
lysosomal membranes modifications and polyamine metabolic perturbations (Roussi et 
al., 2006; 2007; Sottero et al., 2009). On the other hand, caspase-mediated pathways 
and glutathione depletion are suggested as POPs pro-apoptotic mechanisms (Maguire 
et al., 2003; Ryan et al., 2005). Recently, cytotoxic effects of 7β-HC and 7β-
hydroxysitosterol have been compared (Roussi et al., 2005; 2006; 2007). Both types of 
sterol oxides have been found to interact with plasma membranes; 7β-HC induced the 
permeabilization of mitochondrial membrane and the release of endonuclease G to the 
nucleus. The expression of endonuclease G promotes DNA fragmentation and cell 
death. Moreover, 7β-HC enhances ROS formation in the mitochondria, which possibly 
destabilizes the lysosomal membrane. 7β-hydroxysitosterol also raised the 
permeabilization of mitochondrial membrane and the secretion of cytochrome C to 
cytosol. Cytochrome C activates pro-apoptotic factors as well as the maturation of 
caspase-3 and-9, which is intimately related to POP cytotoxic pathway. Furthermore, 
similar to 7β-HC, 7β-hydroxysitosterol disrupts lysosomal membrane integrity.  
 Regarding different types of COPs and POPs, 7-hydroxy, 7-keto and triol 
derivatives are the most cytotoxic ones (Meynier et al., 2005; Ryan et al., 2005).  
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Because of their pro-apopototic and cytotoxic effects, oxysterols could be applied 
to avoid carcinogenesis with interesting results. This pharmacological application has 
already been found in Chinese traditional medicine; antitumoral plants contain 7α/β-
hydroxysitosterol, 7α/β-hydroxycampesterol and ketocampesterol (Schroeder et al., 
1980; Chaurasia and Wichtl, 1987). There is no evidence of these components being 
pharmacologically active, but they could be responsible for anticarcinogenic effects 
(Hovenkamp et al., 2008).  
Pro-inflammatory effects of oxysterols 
Inflammation has been recently associated with several chronic diseases, such 
as obesity, atherogenesis and Alzheimer. As multiple molecules are implicated with 
pro- or anti-inflammatory effects, it is very difficult to study all the routes involved. 
Nevertheless, COPs have been proven to up-regulate the expression of various 
inflammatory molecules, including adhesion molecules, growth factors, cytokines and 
chemokines.  
Regarding inflammatory molecules, 7α/β-HCs and 7-KC seem to induce 
intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-
1) and E-selectin (Lemaire et al., 1998; Romeo et al., 2004). An increase in the 
expression of transforming growth factor β1 (TGF β1), the main fibrogenic cytokine, 
giving rise to the progression of fibroesclerosis within the damaged arterial wall has 
been observed for a mixture of COPs (Leonarduzzi et al., 2001; 2005). The expression 
and synthesis of MCP-1 (monocyte chemotactic protein-1), the major chemokine for 
monocytes/macrophages, in cells of the macrophage lineage (U937 cell line), was also 
increased by a mixture of COPs, being this regulation dependent on a net increment of 
phosphorylation of extracellular signal-regulated kinase 1/2 (ERK 1/2 and nuclear 
factor κB (NF-κB) nuclear binding (Leonarduzzi et al., 2005). 
Interleukin-8 (IL-8), which might be proatherogenic by recruiting T lymphocytes 
and monocytes in the arterial subendothelial space and by inhibiting expression of local 
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tissue inhibition of metalloproteinase-1, is regulated by various COPs basically through 
a calcium-dependent phenomenon involving MEK/ERK ½ pathway and activation of 
AP-1 (Rydeberg et al., 2003; Prunet et al., 2006; Erridge et al., 2007; Lemaire-Ewing et 
al., 2008; 2009; Sottero et al., 2009).  
Also cholesterol oxides might induce atypical gene expression in neural cells that 
may contribute to the etiology or pathogenesis of inflammatory brain disease 
(Alexandrov et al., 2005).   
The modulation of inflammation by POPs has been much less studied 
(Hovenkamp et al., 2008). A mixture of oxidized derivatives of β-sitosterol has shown 
an anti-inflammatory activity in a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced 
inflammation of ears in mice (Kimura et al., 1995). However, these positive effects, 
which have been found only for some oxyphytosterols, have to be confirmed.   
Atherosclerosis induced by oxysterols  
The first COPs were found in atheromatous plaques, suggesting the implication 
of oxysterols in atherogenic processes (Brooks et al., 1966). Moreover, several sterol 
oxidized products have been quantified in LDLs, which are directly involved in 
atherogenesis (Staprans et al., 2003). 
There is growing evidence that suggests oxidized LDLs (oxLDLs) play a major 
role in the injury of endothelium. Its content in COPs serves as the reactive mediator of 
structural and functional changes of the vascular endothelium affected by 
atherosclerotic process (Guardiola et al., 1996; Leonarduzzi et al., 2002). 
Atherogenesis is principally caused by hypercholesterolemia and inflammation 
(Schroepfer, 2000; Steinberg, 2002). Oxidized LDLs are not recognized by LDL 
receptors, they are instead taken up by scavenger receptors on macrophages of 
arterial walls (Stocker et al., 2004). Oxidized LDLs generate lipid derived molecules 
(COPs, peroxidized fatty acids…) that accumulate in the vascular subintimal space. 
They produce monocytes adhesion and transmigration which conclude with the 
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formation of foam cells. The proliferation of foam cells, in addition to inflammation and 
apoptosis, generates a fibrotic cap (atheromatous plaque). The instability and release 
of this plaque can result in thrombosis (Fig. 5) (Steinberg, 2002; Poli et al., 2009).  
<Insert Figure 5> 
Specifically, COPs are involved in various key steps of the atherogenic process: 
1) Endothelial cell dysfunction (increasing permeability). 2) Adhesion and 
transmigration of monocytes (expression of cell adhesion molecules, chemokines and 
cytokines). 3) Generation of foam cells (differentiation of monocytes to macrophages). 
4) Macrophages and smooth muscle cells interaction and extracellular matrix over-
production. 5) Inflammation and fibrotic cap formation. 6) Vascular apoptosis and 
extracellular matrix degradation (Poli et al., 2009). 
Analysis of fibrotic plaques removed from human carotids demonstrated that, , 
27-HC, 7-KC and 7β-HC were accumulated (Garcia-Cruset et al., 1999; 2001). Zhou et 
al. (2000) found that plasma from catheterized patients showed much higher total free 
oxysterols than control ones, being the most abundant of those from autoxidation 
origin. Larsson et al. (2006) showed that increased levels of 7β-HC and 7-KC may play 
an important role in the induction of oxidative stress in atheroma plaques by stimulating 
production of ROS and decreasing cellular antioxidants. Increased COPs levels (mainly 
7-KC and 7β-HC) have been reported in disease states where oxidative stress was 
increased such as diabetes mellitus (Abo et al., 2000) or familial combined 
hyperlipidemia (Arca et al., 2007). In addition, significantly higher concentrations of 
blood COPs were found in the blood of diabetic and hypercholesterolemic patients than 
in the blood of control subjects (Szuchman et al., 2008). Seet et al. (2010) found that 
the levels of plasma 7β-HC, 27-HC and 7-KC, as well as other oxidative markers, were 
elevated in patients of Parkinson disease. The use of COPs as biomarkers could 
improve the early diagnosis of the different diseases in which oxidative stress appears 
to be involved: neurodegenerative diseases, diabetes, obesity…With this information, 
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specific antibodies against 7-KC have been developed, with the aim of detecting 
oxysterols in atherosclerotic lesions (Myoishi et al., 2007).  
On the other hand, triol derivatives have been described as one of the most 
cytotoxic oxysterols to endothelial cells (Meynier et al., 2005). As was pointed out 
before, α-EC is readily metabolised to triol derivatives and these metabolites are one of 
the most abundant COPs in human plasma and tissues (Grandgirard et al., 2004d).  
However, the implication of dietary COPs in atherogenesis is not clear.  Recently, 
COP enriched diets have been associated with atherogenic effects in Apolipoprotein E-
deficient mice (Staprans et al., 2000). Conversely, another study carried out on the 
same animal models showed that oxidized sterols in the diet do not induce 
atherogenesis (Ando et al., 2002). The reason for the apparent discrepancy between 
these studies is unknown but may reside in the different study conditions. Recently, 
Soto-Rodriguez et al. (2009) observed that dietary COPs caused an inflammatory 
process and promoted atherogenesis and atrophy of tissue in rats. 
Furthermore, the role of some oxysterols in intracellular lipid accumulation that 
takes place in atherosclerotic processes is also under research. 7-KC has been 
demonstrated to be a potent apoptotic inducer, causing cytoplasmatic modifications, 
including a reversible formation of myelin figures. These are polar lipid-rich structures, 
containing high levels of phosphatidylcholine and sphingomyelin and localized in acidic 
compartiments, that characterizes phospholipidosis (Vejux et al., 2009).  
As far as POPs are concerned, in vivo studies do not show atherogenic effects 
caused by these oxidized plant sterols (Ando et al., 2002; Tomoyori et al., 2004).  
Beneficial effects of oxysterols 
It appears that sterols oxidized in the ring are implicated in toxic effects, whereas 
sterols oxidized enzymatically in the side chain play important biological roles (Gill et 
al., 2008). 
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COPs in membrane structures and their effects on permeability 
Cholesterol is required to build and maintain membranes, decreasing their fluidity 
and permeability and promoting the formation of special liquid-ordered microdomains 
that are known as lipid rafts. Because of their homology, COPs are also inserted in the 
membrane but, in general, their condensing and ordering capability is lower. However, 
it has been shown that depending on the composition of the phospholipid matrix, 
oxysterols may induce or inhibit membrane permeability (Sottero et al., 2009).  
Cholesterol homeostasis regulated by COPs 
Several COPs are associated with the cholesterol homeostasis through different 
mechanisms:  
a) Sterol Regulatory Element Binding Protein (SREBP) blockade 
Sterol regulatory element binding protein (SREBP) is produced in endoplasmic 
reticulum (ER) and controls the expression of genes involved in cholesterol synthesis. 
It is bound to the SREBP-cleaveage activating protein (SCAP) which is like a 
cholesterol sensor; if cholesterol levels are low, SCAP releases SREBP and the gene 
transcription is stimulated. However, when cholesterol levels are high, Insig (insulin 
induced gene) protein retains SCAP-SREBP complex in ER and the gene transcription 
is inhibited. Moreover, cholesterol production may be stopped by the cholesterol 
binding to SPAC, when cholesterol levels are increased in ER.  
Similarly, it has been shown that COPs can block SREBP-SCAP by their union 
with Insig protein. Specifically, 24(S),25-epoxycholesterol (24(S),25-EC) is bound to the 
Insig element and inhibits the synthesis of cholesterol (Lund et al., 1998; Gill et al., 
2008). 
b) Degradation of 3-hydroxy-3-methil-glutaryl-CoA (HMC-CoA) reductase  
3-hydroxy-3-methil-glutaryl-CoA (HMC-CoA) reductase is one of the proteins 
expressed when SREBP reaches the nucleus for gene transcription. HMC-CoA 
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reductase catalyzes the conversion of HMG-CoA to mavelonate, one of the steps in 
cholesterol synthesis. 27-hydroxycholesterol seems to degrade this enzyme, inhibiting 
cholesterol production (Lange et al., 2008).  
c) Oxycholesterol stimulate Liver X Receptor (LXR) 
24(S),25-EC is found to bind LXR, which regulates the transcription of a number 
of genes involved in lipid metabolism, including those of the ABC transporters (Chen et 
al., 2007). Members of ABC family transporters are implicated in the excretion of 
sterols and oxysterols from the cell, as was mentioned earlier. Therefore, when 
24(S),25-EC binds LXR, cholesterol excretion will be stimulated.  
d) Sterol transport: stimulation and inhibition 
Some studies have demonstrated that oxysterols (24(S)-HC and 27-HC) could 
transport sterols to the liver regulating their incorporation to HDL (Björkhem et al., 
1994; 1998; Lund et al., 1996). Conversely, other studies have showed that 7-KC 
inhibits the export of cholesterol to HDL, accumulating cholesterol in cells (Jessup et 
al., 2002). 
It has been noticed that 24(S),25-EC plays an important role in cholesterol 
homeostasis, blocking SERBP and stimulating the transcription of ABC transporters 
(Chen et al., 2007; Gill et al., 2008; Brown and Jessup, 2009). These effects in 
cholesterol homeostasis could also regulate oxysterol synthesis and degradation; 
stimulation of ACAT, inhibition of the incorporation to HDL and other mechanisms are 
proposed (Leonarduzzi et al., 2002). 
Possible beneficial effects of POPs 
Extensive literature data demonstrate the efficacy of phytosterols to decrease 
serum cholesterol in humans  (Katan et al., 2003; Berger et al., 2004). Different 
mechanisms are involved: phytosterols are able to inhibit cholesterol absorption in the 
intestine competing with cholesterol in the formation of lipid micelles or precipitating 
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cholesterol in the gut. Also, plant sterols activate LXR in order to increase cholesterol 
excretion to the intestinal lumen, and inhibit the ACAT enzyme from decreasing 
cholesterol esterification (Plat and Mensink, 2002; Plat et al., 2005). In this last paper, 
Plat et al. (2005) suggested that some POPs (those formed by enzymatic oxidation of 
the side chain) may be also  involved in the modulation of cholesterol metabolism via 
LXR activation and increment of ABC transporters expression. In any case, for LXR 
regulation by naturally present forms of oxyphytosterols less evidence is available 
(Hovenkamp et al., 2008). 
 On the other hand, studies developed in vitro with POPs revealed that they may 
induce an increase in plasma sex steroids and an acceleration of spermatogenesis 
(androgen effects) (Christiansion-Heika et al., 2007). In addition, an oxycampesterol 
(campestenone) has been found to reduce body weight gain, visceral fat deposition, 
serum triacyglycerols and blood glucose in mice and rats (Suzuki et al., 2002; Ikeda et 
al., 2006). However, these hypotheses still need to be deeply studied in humans (Ryan 
et al., 2009). 
Conclusion 
The world of oxysterols is a wide field and still needs a lot of research. It seems 
clear the implication of COPs in several toxic effects whereas in the case of POPs, 
there is a lack of scientific evidence in this sense.  The commercialization of 
phytosterols enriched  foods makes necessary the evaluation of the biological effects of 
POPs that can be formed from those plant sterols. Also some data suggest that this 
type of compounds could be related to biological positive effects, so the balance of all 
these effects deserves to be studied.  
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Tables and Figures 
Figure 1 
Fig. 1: Cholesterol and main phytosterols´ structures.  
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Figure 2 
Fig. 2: Enzymatic and non-enzymatic production of the main cholesterol oxidation products (COPs) from 
cholesterol. In general, COPs oxygenated on the sterol ring are produced non-enzymatically, while COPs 
oxygenated on the side-chain require enzymes for their formation. 25- and 7α- hydroxycholesterols can be 
generated by both metabolic pathways.  
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Figure 3 
Fig. 3: Main oxysterol structures.  
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Figure 4 
Fig. 4: Sterol and probably oxysterol absorption, esterification and incorporation into chylomicrons. 
NPC1L1: lipid micelle transporter; ABC: ATP Binding Cassette transporters; ACAT: Acyl-coA Cholesterol 
Acyl Transferase; TG: Triglycerides; MPT: Microsomal TG transfer protein; QM: Chylomicrons; HDL: High 
Density Lipoprotein; SR-B1: Scavenger Receptor type B. Source: Menéndez-Carreño, 2009. 
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Figure 5 
Fig. 5: Scheme of atherogenic process. LT: T lymphocyte; LDL: Low Density Lipoproteins. Source: 
Menéndez-Carreño, 2009.  
 
ATHEROMATOUS 
Monocyte 
Activated 
monocyte
Macrophage
Foa
Ox-LDL  
Citokine
LT  
O2 
H2O2 
Endotelio 
Native LDL 
Smooth muscle cells 
Platelet 
ti
PLAQUE
 LUMEN 
 
IN
MEDIA 
 
 
 
 
Endothelial 
cells
 
 
 
 32
Table 1 
Table 1: Quantity of phytosterol oxidation products (POPs) and cholesterol oxidation products (COPs) in 
different types of foods.  
St: Stigmasterol oxides; Si: β-sitosterol oxides; C: Campesterol oxides; B: Brassicasterol oxides; Sol: 
Sitostanol oxides. 
Food Sample POPs Total COPs Reference 
Oils    
Hazelnut oil 
Rapeseed oil 
10.6 μg/g oil  (St, Si, 
C) 
~63.0 μg/g oil (Si, 
C, B) 
 
Azadmard-Damirchi 
and Dutta, 2009 
Rapeseed oil 102.4 μg/g oil (St, 
Si, C) 
 
Kmiecik et al., 2009 
Sunflower oil 
Soybean oil 
Olive oil 
Rapeseed oil 
9.6 μg/g oil (Si) 
0.8 μg/g oil (Si) 
<0.1 μg/g oil (Si) 
1.9 μg/g oil (Si) 
 
Zhang et al., 2006 
Sunflower oil 
High-oleic 
sunflower oil 
39.9 μg/g oil 
46.7 μg/g oil 
 
Dutta, 1997 
Extra virgin olive 
oil 
3.3  μg/g oil (Si)  
D´Evoli et al., 2006 
Peanut oil 
Sunflower oil 
Corn oil 
Lampante oil 
Palm nut oil 
2.7-9.6 ppm (St, Si, 
C) 
4.5-67.5 ppm (St, 
Si, C) 
4.1-60.1 ppm (St, 
Si, C) 
1.5-2.5 ppm (St, Si, 
C) 
5.5 ppm (St, Si, C) 
 
Bortolomeazzi et al., 
2003 
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Non-enriched 
spread 
13.3  μg/g (St, Si, C)  Conchillo et al., 
2005b 
Dairy products    
Whole milk 
powders 
 1.1 μg/g 
Angulo et al., 1997 
Butter  13.7-27.3 
μg/g 
Pie et al., 1990 
Ghee (fresh)  259.0  μg/g Jacobson, 1987 
Egg and egg 
products 
  
 
Commercial 
pasteurized liquid eggs 
 3.3-3.8 μg/g 
Guardiola, 1994 
Commercial 
spray-dried whole eggs 
 29.0-294.3 
μg/g 
Sander et al., 1989 
Pie et al., 1990 
Sarantinos et al., 
1993 
Freeze-dried egg 
yolks 
 28.8-43.5 
μg/g fat 
Pignoli et al., 2009 
Dried egg pasta  43.8-52.0 
μg/g fat 
Verardo et al., 2010 
Meat and meat 
products 
  
 
Beef  0.1 μg/g Boselli et al., 2009 
Beef  <8.0 μg/g Ferioli et al., 2010 
Minced beef 
Minced pork 
Minced veal 
 3.4 μg/g 
2.2 μg/g 
1.8 μg/g 
Pie et al., 1991 
Chicken 
Beef 
 4.0 ppm 
2.3 ppm 
Echarte et al., 2003 
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Chicken  0.2 μg/g Zubillaga and 
Maerker, 1991 
Precooked 
chicken patties 
 17.6  μg/g 
fat 
Bonoli et al., 2008 
Hamburger 
Commercial raw 
ham 
Commercial 
sausage 
 2.6-9.7 μg/g 
0.5-10.5 
μg/g 
3.7-7.3 μg/g 
Osada et al., 2000 
Dry-cured ham  0.8 ppm Sánchez-Molinero et 
al., 2010 
Turkey meat  23.7  μg/g 
fat 
Boselli et al., 2005 
Commercial 
turkey 
 6.0-21.0 
μg/g 
Sander et al., 1989 
Commercial 
mortadella 
 0.6-18.7 
μg/g 
Novelli et al., 1998 
Sausages  0.6 μg/g fat García-Iñiguez de 
Ciriano et al., 2009 
Sausages  4.7 μg/g Talon et al., 2008 
Milano-type 
sausages 
 0.5 μg/g 
Zanardi et al., 2001 
Salame Milano 
Pancetta 
 0.6 μg/g 
1.0 μg/g 
0.3 μg/g 
Zanardi et al., 2009 
Coppa 
Pork chops  8.7 μg/g fat 
6.4 μg/g fat 
10.7 μg/g fat 
 
2.2 μg/g fat 
Beef chops 
Turkey chops 
coated with 
breadcrumbs 
Derewiaka and 
Obiedziński, 2009 
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Cordon blue 
chops coated with 
breadcrumbs 
Machaca (dried-
beef) 
Chicharrón 
(deep-fried-pork rinds) 
 ~ 4.9 
mg/100 g  
~ 5.1 
mg/100 g  
 
Soto-Rodríguez et 
al., 2008 
Seafood and seafood products   
Salmon  0.7 μg/g fat Echarte et al., 2001 
Anchovy  33.6 μg/g Shozen et al., 1997 
Brazilian 
sardines 
 19.4 μg/g 
Saldanha et al., 2008 
Canned tuna  119.9 μg/g 
fat 
Zunin et al., 2001 
Sun-dried-
shrimp 
 18.1 mg/100 
g 
Soto-Rodríguez et 
al., 2008 
Other foods    
Infant food with 
honey 
Infant food with 
fruits 
69.9 μg/100 g (St, 
Si, C) 
27.9 μg/100 
g 
23.4 μg/100 
g 
García-Llatas et al., 
2008 63.8 μg/100 g (St, 
Si, C) 
Potato crisps 1.5 μg/g fat (STAR 
brand)-21.3 μg/g fat 
(Fragancia brand) (St, Si, C) 
 
Tabee et al., 2008 
Enriched products    
Phytosterol-
enriched spread 
12.0 μg/g (St, Si, C)  Johnsson and Dutta, 
2006 
Phytosterol- 46.5  μg/g (St, Si, C)  Conchillo et al., 
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enriched spread 2005b 
Stigmasterol-
enriched (1%) purified 
rapeseed oil 
Sitostanol-
enriched (1%) purified 
rapeseed oil 
6.6 μg/g oil (St) 
 
0.4 μg/g oil (Sol) 
 
Soupas et al., 2004 
Phytosterol-
enriched milk 
100.0 μg/g fat (St, 
Si, C) 
32.0 μg/g fat Menéndez-Carreño 
et al., 2008 
Eggs enriched 
with n-3 fatty acids 
 7.2-8.4 μg/g 
yolk 
Mazalli and 
Bragagnolo, 2009 
Parmesan (150 
g.) and salami (150 g.) 
 8.6 μmol Linseisen and 
Wolfram, 1998 
Sausages 
enriched in synthetic 
antioxidants 
 0.5 μg/g fat 
 
0.6 μg/g fat 
Sausages 
enriched in natural 
antioxidants 
 
García-Iñiguez de 
Ciriano et al., 2009 
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